An anonymous director reports

MEDIPHARM CAUTIONS SHAREHOLDERS TO AWAIT FINAL RESULTS OF ANNUAL AND SPECIAL MEETING

Medipharm Labs Corp. has responded to a misleading press release published earlier today by Apollo Technology Capital Corp. prematurely claiming that it considers the results of the annual and special meeting of shareholders scheduled to take place at 3 p.m. today to be a clear victory for Apollo.

Medipharm wishes to assure its shareholders that, as the meeting has not yet taken place, the results are not yet available. Medipharm will announce the final results of the meeting in the ordinary course as is required by law and the rules of the Toronto Stock Exchange.

About Medipharm Labs Corp.

Founded in 2015, Medipharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a good-manufacturing-practice-certified facility with ISO-standard-built (International Organization for Standardization) clean rooms. Medipharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities for delivery of pure, trusted and precision-dosed cannabis products for its customers. Medipharm Labs develops, formulates, processes, packages and distributes cannabis and advanced cannabinoid-based products to domestic and international medical markets.

In 2021, Medipharm Labs received a pharmaceutical drug establishment licence from Health Canada, becoming the only company in North America to hold a commercial-scale domestic good manufacturing practice licence for the extraction of multiple natural cannabinoids. This GMP licence was the first step in the company's current foreign drug manufacturing site registration with the U.S. Food and Drug Administration.

In 2023, Medipharm acquired Vivo Cannabis Inc., which expanded Medipharm's reach to medical patients in Canada through Canna Farms medical e-commerce platform and in Australia and Germany through Beacon Medical Australia Pty. Ltd. and Beacon Medical Germany GmbH. This acquisition also included Harvest Medical Clinics in Canada, which provides medical cannabis patients with physician consultations for medical cannabis education and prescriptions.

The company carries out its operations in compliance with all applicable laws in the countries in which it operates.

We seek Safe Harbor.